FDA.reportPublic FDA data

quizartinib 17.7 MG Oral Tablet [Vanflyta]

RxCUI
2643060
RxNorm name
quizartinib 17.7 MG Oral Tablet [Vanflyta]
Display name
quizartinib 17.7 MG Oral Tablet [Vanflyta]
Full name
quizartinib 17.7 MG Oral Tablet [Vanflyta]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:51

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
29cdbcfe-497d-4e78-bb7b-2d4acafe8e86quizartinib 17.7 MG Oral Tablet [Vanflyta]SBD11These highlights do not include all the information needed to use VANFLYTA safely and effectively. See full prescribing information for VANFLYTA. VANFLYTA ® (quizartinib) tablets, for oral use Initial U.S. Approval: 202320260416
29cdbcfe-497d-4e78-bb7b-2d4acafe8e86Vanflyta 17.7 MG Oral TabletSY11These highlights do not include all the information needed to use VANFLYTA safely and effectively. See full prescribing information for VANFLYTA. VANFLYTA ® (quizartinib) tablets, for oral use Initial U.S. Approval: 202320260416
29cdbcfe-497d-4e78-bb7b-2d4acafe8e86Vanflyta 17.7 MG (equivalent to 20 MG quizartinib dihydrochloride) Oral TabletSY11These highlights do not include all the information needed to use VANFLYTA safely and effectively. See full prescribing information for VANFLYTA. VANFLYTA ® (quizartinib) tablets, for oral use Initial U.S. Approval: 202320260416
29cdbcfe-497d-4e78-bb7b-2d4acafe8e86VANFLYTA 17.7 MG Oral TabletPSN11These highlights do not include all the information needed to use VANFLYTA safely and effectively. See full prescribing information for VANFLYTA. VANFLYTA ® (quizartinib) tablets, for oral use Initial U.S. Approval: 202320260416